Floatz logo

Gadobutrol

Chronic Hepatitis

Yonsei UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Chronic Hepatitis cohort.

Asset / SponsorPhaseRating
Meperidine
Erasme University Hospital
Phase 4BB
MIDAZOLAM
Erasme University Hospital
Phase 4BB
Autologous Bone Marrow Mononuclear Cell Intra-Arterial
Hospital Sao Rafael
Phase 2CCC
Rocakinogene Sifuplasmid
National Cancer Institute (NCI)
Phase 1CC
Hcv Dna Vaccine Ino-8000
National Cancer Institute (NCI)
Phase 1CC

Same molecule, other indications

Gadobutrol is also rated in:

cognitive disorderDormant
BB
Indicative ·
65 / 100
View asset →
Contrast MediaDormant
BB
Indicative ·
65 / 100
View asset →
Magnetic Resonance ImagingDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →